According to Editas Medicine
's latest financial reports the company has โน23.24 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โน23.15 B | -13.92% |
2023-12-31 | โน26.89 B | -5.58% |
2022-12-31 | โน28.48 B | -23.43% |
2021-12-31 | โน37.20 B | 26.51% |
2020-12-31 | โน29.40 B | -9.79% |
2019-12-31 | โน32.59 B | 26.36% |
2018-12-31 | โน25.79 B | 22.76% |
2017-12-31 | โน21.01 B | 66.88% |
2016-12-31 | โน12.59 B | 32.35% |
2015-12-31 | โน9.51 B | 1313.27% |
2014-12-31 | โน0.67 B | 441.64% |
2013-12-31 | โน0.12 B |